Purpose: To revolutionize dementia treatment and care through a low-cost, 5-minute blood test that detects and distinguishes all major forms of dementia early
Vision: To pioneer the first global dementia screening program using the Brainalyze blood test
________________________________________
Breakthrough innovation
MX-Raman™: Proprietary platform technology that combines optical ‘fingerprinting’ + interpretable AI
• Multiple lasers excite Raman scattering to create an optically-generated biochemical ‘fingerprint’
• AI uses optical fingerprint data for classification and prediction analysis
• Only platform capable of broad-spectrum dementia detection and differentiation
• 5-minute test | Costs <10% of current tests | Portable & scalable
________________________________________
USP
• Beyond biomarkers: Competing blood tests (e.g. pTau217) detect only Alzheimer’s. MX-Raman detects and differentiates all major dementias
• Simple single-step test: No reagents, antibodies, dyes required nor complex infrastructure, sophisticated equipment. Does not involve multiple steps unlike current tests.
• Speed, cost and size: 100x faster and <10% of the costs of existing tests (imaging or biomarker based), <1m2 footprint
• Versatile use cases: Early screening, patient triage, differential diagnosis, treatment monitoring, clinical trial stratification and companion diagnosis
________________________________________
IP & Defensibility
• Patent pending in UK, EU, US (PCT/GB2022/053117) covering method, device and use cases
• Proprietary and unique spectral database, AI analysis models, know-how and trade-secrets
• Technology developed through 12 years of academic research
________________________________________
Progress to Date
• Funding: $1.8M translational research funding already available
• Clinical feasibility and traction: >400 patient samples tested, published 93%+ diagnostic accuracy, >1200 patient samples further secured
• Device: Prototype and AI analysis models developed
Company Details
- Employees
- 4
- Founded
- -
- Address
- University Road, Southampton,so17 1bj So17 1bj,united Kingdom
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- http://www.brainalyze.co.uk
- Keywords
- Dementia, Neurodegenerative Diseases, Detection, Diagnosis, Screening, Optical fingerprinting technology.
- HQ
- Southampton, SO17 1BJ
Brainalyze Questions
Brainalyze's website is http://www.brainalyze.co.uk
Brainalyze's LinkedIn profile is https://www.linkedin.com/company/brainalyze
Brainalyze has
4 employees.
View email and phone details for 4
employees at Brainalyze.
Brainalyze's industry is
Medical and Diagnostic Laboratories
Brainalyze's top competitors are
Idcp Scotland,
Revolver Therapeutics,
Silatech,
Future Worlds,
Blocktopus,
Targopep Ltd,
Eos Space Technology Ltd,
Bloctopus,
Droplet Scientific Ltd,
Mytender.io.
Brainalyze's categories are Medical and Diagnostic Laboratories
Brainalyze's founding year is 2025
